Vivos (RDGL) Current Leases (2010 - 2025)

Vivos' (RDGL) quarterly Current Leases came in at $25420.0 in Q4 2025, down 35.61% quarter-over-quarter from $39481.0 in Q4 2014.

Vivos (RDGL) Current Leases (2010 - 2025) Analysis & Trends

Vivos has disclosed Current Leases across 6 years of filings, most recently posting $25420.0 for Q4 2025.

Current Leases for Q4 2025 came in at $25420.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $25420.0 (changed N/A YoY), and the FY2025 annual result was $25420.0, changed N/A from the prior year.
Current Leases came in at $25420.0 for Q4 2025 at Vivos, down from $39481.0 in the prior quarter.
In the past five years, Current Leases ranged from a high of $25420.0 in Q4 2025 to a low of $25420.0 in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	24.30 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	20.50 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	35.80 Mn
10	Vivos	-	-	-3,105.00	25,420.00

Historic Data

Download Data

Date	Value
Dec 31, 2025	25,420.00
Dec 31, 2014	39,481.00
Sep 30, 2014	109,421.00
Jun 30, 2014	177,645.00
Mar 31, 2014	244,648.00
Dec 31, 2013	309,145.00
Sep 30, 2013	264,607.00
Jun 30, 2013	175,287.00
Mar 31, 2013	319,505.00
Dec 31, 2012	346,270.00
Sep 30, 2012	366,768.00
Jun 30, 2012	815,708.00
Mar 31, 2012	925,033.00
Dec 31, 2011	427,813.00
Sep 30, 2011	425,000.00
Jun 30, 2011	417,000.00
Dec 31, 2010	405,338.00